Aggressive basal cell carcinoma

Presentation, pathogenesis, and management

Hobart W. Walling, Scott Fosko, Pedram A. Geraminejad, Duane C. Whitaker, Christopher J. Arpey

Research output: Contribution to journalReview article

187 Citations (Scopus)

Abstract

Basal cell carcinoma (BCC) is the most common cutaneous skin malignancy. BCC generally has a clinical course characterized by slow growth, minimal soft tissue invasiveness, and a high cure rate. Occasionally, however, BCC behaves aggressively with deep invasion, recurrence, and potential regional and distant metastasis. Several factors, including tumor size, duration, histology, and perineural spread, have been postulated as markers of the aggressive BCC phenotype. It is undetermined whether intrinsic biological factors within certain subsets of BCC predispose these tumors toward an inherently aggressive behavior, or whether any BCC with inadequate early management may assume this phenotype. Review of the pertinent literature on this topic suggests that both intrinsic biological factors and extrinsic management factors play a role in the development and progression of aggressive BCC.

Original languageEnglish (US)
Pages (from-to)389-402
Number of pages14
JournalCancer and Metastasis Reviews
Volume23
Issue number3-4
DOIs
StatePublished - Aug 1 2004
Externally publishedYes

Fingerprint

Basal Cell Carcinoma
Intrinsic Factor
Biological Factors
Phenotype
Neoplasms
Skin
Histology
Neoplasm Metastasis
Recurrence
Growth

Keywords

  • Bcl2
  • cryotherapy
  • curettage
  • cyclin
  • imiquimod
  • pyrimidine dimer

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Aggressive basal cell carcinoma : Presentation, pathogenesis, and management. / Walling, Hobart W.; Fosko, Scott; Geraminejad, Pedram A.; Whitaker, Duane C.; Arpey, Christopher J.

In: Cancer and Metastasis Reviews, Vol. 23, No. 3-4, 01.08.2004, p. 389-402.

Research output: Contribution to journalReview article

Walling, Hobart W. ; Fosko, Scott ; Geraminejad, Pedram A. ; Whitaker, Duane C. ; Arpey, Christopher J. / Aggressive basal cell carcinoma : Presentation, pathogenesis, and management. In: Cancer and Metastasis Reviews. 2004 ; Vol. 23, No. 3-4. pp. 389-402.
@article{c07e2c924f6f4450be7d8ff1f194045b,
title = "Aggressive basal cell carcinoma: Presentation, pathogenesis, and management",
abstract = "Basal cell carcinoma (BCC) is the most common cutaneous skin malignancy. BCC generally has a clinical course characterized by slow growth, minimal soft tissue invasiveness, and a high cure rate. Occasionally, however, BCC behaves aggressively with deep invasion, recurrence, and potential regional and distant metastasis. Several factors, including tumor size, duration, histology, and perineural spread, have been postulated as markers of the aggressive BCC phenotype. It is undetermined whether intrinsic biological factors within certain subsets of BCC predispose these tumors toward an inherently aggressive behavior, or whether any BCC with inadequate early management may assume this phenotype. Review of the pertinent literature on this topic suggests that both intrinsic biological factors and extrinsic management factors play a role in the development and progression of aggressive BCC.",
keywords = "Bcl2, cryotherapy, curettage, cyclin, imiquimod, pyrimidine dimer",
author = "Walling, {Hobart W.} and Scott Fosko and Geraminejad, {Pedram A.} and Whitaker, {Duane C.} and Arpey, {Christopher J.}",
year = "2004",
month = "8",
day = "1",
doi = "10.1023/B:CANC.0000031775.04618.30",
language = "English (US)",
volume = "23",
pages = "389--402",
journal = "Cancer and Metastasis Reviews",
issn = "0167-7659",
publisher = "Springer Netherlands",
number = "3-4",

}

TY - JOUR

T1 - Aggressive basal cell carcinoma

T2 - Presentation, pathogenesis, and management

AU - Walling, Hobart W.

AU - Fosko, Scott

AU - Geraminejad, Pedram A.

AU - Whitaker, Duane C.

AU - Arpey, Christopher J.

PY - 2004/8/1

Y1 - 2004/8/1

N2 - Basal cell carcinoma (BCC) is the most common cutaneous skin malignancy. BCC generally has a clinical course characterized by slow growth, minimal soft tissue invasiveness, and a high cure rate. Occasionally, however, BCC behaves aggressively with deep invasion, recurrence, and potential regional and distant metastasis. Several factors, including tumor size, duration, histology, and perineural spread, have been postulated as markers of the aggressive BCC phenotype. It is undetermined whether intrinsic biological factors within certain subsets of BCC predispose these tumors toward an inherently aggressive behavior, or whether any BCC with inadequate early management may assume this phenotype. Review of the pertinent literature on this topic suggests that both intrinsic biological factors and extrinsic management factors play a role in the development and progression of aggressive BCC.

AB - Basal cell carcinoma (BCC) is the most common cutaneous skin malignancy. BCC generally has a clinical course characterized by slow growth, minimal soft tissue invasiveness, and a high cure rate. Occasionally, however, BCC behaves aggressively with deep invasion, recurrence, and potential regional and distant metastasis. Several factors, including tumor size, duration, histology, and perineural spread, have been postulated as markers of the aggressive BCC phenotype. It is undetermined whether intrinsic biological factors within certain subsets of BCC predispose these tumors toward an inherently aggressive behavior, or whether any BCC with inadequate early management may assume this phenotype. Review of the pertinent literature on this topic suggests that both intrinsic biological factors and extrinsic management factors play a role in the development and progression of aggressive BCC.

KW - Bcl2

KW - cryotherapy

KW - curettage

KW - cyclin

KW - imiquimod

KW - pyrimidine dimer

UR - http://www.scopus.com/inward/record.url?scp=3042818253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042818253&partnerID=8YFLogxK

U2 - 10.1023/B:CANC.0000031775.04618.30

DO - 10.1023/B:CANC.0000031775.04618.30

M3 - Review article

VL - 23

SP - 389

EP - 402

JO - Cancer and Metastasis Reviews

JF - Cancer and Metastasis Reviews

SN - 0167-7659

IS - 3-4

ER -